Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy

Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy

Background: COVID-19-associated coagulopathy (CAC) exacerbates the course of coronavirus infection and contributes to increased mortality. Current recommendations for CAC treatment include the use of low-molecular weight heparins (LMWH) at prophylactic or therapeutic doses, as well as the use of unf...

Full description

Bibliographic Details
Main Authors: Oleksandr Oliynyk, Wojciech Barg, Anna Slifirczyk, Yanina Oliynyk, Serhij Dubrov, Vitaliy Gurianov, Marta Rorat
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Life
Subjects:
anticoagulant therapy
blood coagulation
SARS-CoV-2
respiratory failure
Online Access:https://www.mdpi.com/2075-1729/11/10/1032

Similar Items

Similar Items